{"article_title": "Biotech hammered as ETFs down 5%, while some stocks fall 10%", "article_keywords": ["sector", "biotech", "getting", "twitter", "hammered", "pharmaceuticals", "etfs", "biotechnology", "etf", "nearly", "fall", "health", "stocks", "dropped"], "article_url": "http://blogs.marketwatch.com/health-exchange/2014/04/10/biotech-hammered-as-etfs-down-5-while-some-stocks-fall-10/", "article_text": "Biotechnology stocks hit a steep slide Thursday with all major exchange-traded funds in the sector down more than 5% and a number of individual equities down 10% or more amid broader market declines.\n\nShutterstock\n\nThe bellwether iShares Nasdaq Biotechnology ETF /quotes/zigman/85342/delayed /quotes/nls/ibb IBB was off nearly 6% in early afternoon trades while the SPDR S&P Biotech ETF fell more than 6%.\n\nThe drop was puzzling to ISI Group analyst Mark Schoenebaum.\n\n\u201cI frankly just don\u2019t know why biotech is off so much today,\u201d he said in a note to clients.\n\nSome of the most volatile stocks in the sector of late were getting hammered, with double-digit losses. Intercept Pharmaceuticals /quotes/zigman/12230574/delayed /quotes/nls/icpt ICPT tumbled more than 11% to $265.12. Pharmacyclics Inc. /quotes/zigman/53242/delayed /quotes/nls/pcyc PCYC also dropped 11%, going to $91.70.\n\nAnd big-name players weren\u2019t immune to the selloff either. Alexion Pharmaceuticals Inc. /quotes/zigman/59581/delayed /quotes/nls/alxn ALXN dropped more than 8% to $142.59, while Gilead Sciences Inc. /quotes/zigman/72849/delayed /quotes/nls/gild GILD lost nearly 8% to $65.15.\n\nFollow Russ Britt on Twitter @russbrittmktw.\n\nFollow Health Exchange on Twitter @MWHealthBlog.\n\nMore health-care news from MarketWatch:\n\nRyan, Rubio working on Obamacare alternative?\n\nTechnology could take money out of health providers\u2019 hands\n\nMore children, and low-income kids, getting insured", "article_metadata": {"article.created": "2014-04-10T13:55:08-04:00", "application-name": "MarketWatch.com", "twitter": {"domain": "Marketwatch.com", "description": "Biotechnology stocks hit a steep slide with all major exchange-traded funds in the sector down more than 5% and a number of individual equities down 10% or more amid broader declines.", "title": "Biotech hammered as ETFs down 5%, while some stocks fall 10%", "url": "http://blogs.marketwatch.com/health-exchange/2014/04/10/biotech-hammered-as-etfs-down-5-while-some-stocks-fall-10/", "image": {"src": "http://s.wsj.net/public/resources/MWimages/MW-BX388_biotec_MG_20140324071824.jpg"}, "site": "MarketWatch", "card": "summary_large_image"}, "article.author": "Russ Britt", "article.section": "Markets", "keywords": "Alexion Pharmaceuticals Inc.,biotechnology,Gilead Sciences Inc.,health care,Stock movers", "article.headline": "Biotech hammered as ETFs down 5%, while some stocks fall 10%", "msapplication-task": "name=SmartMoney;action-uri=http://www.smartmoney.com/;icon-uri=http://www.smartmoney.com/favicon.ico", "description": "Biotechnology stocks hit a steep slide with all major exchange-traded funds in the sector down more than 5% and a number of individual equities down 10% or more amid broader declines.", "author": "Russ Britt", "article.page": "Health Exchange Blog", "news_keywords": "Alexion Pharmaceuticals Inc.,biotechnology,Gilead Sciences Inc.,health care,Stock movers", "article.published": "2014-04-10T13:55:08-04:00", "ROBOTS": "noarchive, noodp", "msapplication-tooltip": "MarketWatch", "fb": {"url": "http://blogs.marketwatch.com/health-exchange/2014/04/10/biotech-hammered-as-etfs-down-5-while-some-stocks-fall-10/", "app_id": 283204329838}, "article": {"publisher": "https://www.facebook.com/marketwatch", "image_count": 2}, "og": {"site_name": "Marketwatch", "description": "Biotechnology stocks hit a steep slide with all major exchange-traded funds in the sector down more than 5% and a number of individual equities down 10% or more amid broader declines.", "title": "Biotech hammered as ETFs down 5%, while some stocks fall 10%", "url": "http://blogs.marketwatch.com/health-exchange/2014/04/10/biotech-hammered-as-etfs-down-5-while-some-stocks-fall-10/", "image": {"width": 569, "identifier": "http://s.wsj.net/public/resources/MWimages/MW-BX388_biotec_MG_20140324071824.jpg", "height": 398}, "type": "article"}, "article.access": "free", "article.type": "Health Exchange", "article.id": "BL-MW243B-2390", "article.updated": "2014-04-10T13:55:08-04:00"}, "_id": "\"57477af36914bd0286fd3ced\"", "article_summary": "ShutterstockThe bellwether iShares Nasdaq Biotechnology ETF /quotes/zigman/85342/delayed /quotes/nls/ibb IBB was off nearly 6% in early afternoon trades while the SPDR S&P Biotech ETF fell more than 6%.\nSome of the most volatile stocks in the sector of late were getting hammered, with double-digit losses.\nBiotechnology stocks hit a steep slide Thursday with all major exchange-traded funds in the sector down more than 5% and a number of individual equities down 10% or more amid broader market declines.\n\u201cI frankly just don\u2019t know why biotech is off so much today,\u201d he said in a note to clients.\nTechnology could take money out of health providers\u2019 handsMore children, and low-income kids, getting insured"}